M&A Deal Summary

Tectonic Therapeutic Acquires Tectonic Therapeutic /old/

On January 30, 2024, Tectonic Therapeutic acquired life science company Tectonic Therapeutic /old/ from Polaris Partners

Acquisition Highlights
  • This is Tectonic Therapeutic’s 1st transaction in the Life Science sector.
  • This is Tectonic Therapeutic’s 1st transaction in the United States.
  • This is Tectonic Therapeutic’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2024-01-30
Target Tectonic Therapeutic /old/
Sector Life Science
Buyer(s) Tectonic Therapeutic
Sellers(s) Polaris Partners
Deal Type Add-on Acquisition
Advisor(s) Leerink Partners
Piper Sandler & Co. (Financial)
Cooley (Legal)

Target

Tectonic Therapeutic /old/

Watertown, Massachusetts, United States
Tectonic Therapeutic aims to transform the discovery of novel drugs addressing targets in the GPCR family. Tectonic Therapeutic was founded in 2019 and is based in Watertown, Massachusetts.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tectonic Therapeutic

Watertown, Massachusetts, United States

Category Company
Sector Life Science
Employees51
DESCRIPTION

Tectonic Therapeutic is a biotechnology company developing lentiviral-based gene therapies to treat lysosomal storage disorders (LSDs). Tectonic Therapeutic is based in Watertown, Massachusetts.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1

Seller(S) 1

SELLER

Polaris Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.


DEAL STATS #
Overall 30 of 37
Sector: Life Science M&A 6 of 8
Type: Add-on Acquisition M&A Deals 13 of 19
State: Massachusetts M&A 5 of 7
Country: United States M&A 28 of 34
Year: 2024 M&A 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-14 Capstan

San Diego, California, United States

Capstan Therapeutics is developing a targeted delivery platform and therapeutics to reprogram immune cells in vivo for a broad range of disease categories. Capstan was founded in 2021 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-05-21 Baxter Planning

Austin, Texas, United States

Baxter Planning is a supply chain software company, providing AI-powered solutions for service parts planning, execution, and resolution. The company serves industries such as high-tech, life sciences, telecommunications, aerospace and defense, oil and gas, and industrial machinery, helping clients optimize inventory, reduce costs, and enhance customer satisfaction. Its flagship platform, BaxterPredict, integrates predictive analytics and automation to streamline service operations and improve supply chain performance. Baxter Planning was formed in 1993 and is based in Austin, Texas.

Sell -